Putnam Investments’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$105M Buy
189,978
+5,624
+3% +$2.64M 0.14% 118
2023
Q3
$80.6M Sell
184,354
-2,535
-1% -$1.26M 0.12% 124
2023
Q2
$93.9M Buy
186,889
+8,180
+5% +$3.92M 0.14% 122
2023
Q1
$89.4M Sell
178,709
-10,134
-5% -$4.85M 0.14% 122
2022
Q4
$77M Buy
188,843
+1,361
+0.7% +$528K 0.13% 130
2022
Q3
$61.1M Sell
187,482
-100,900
-35% -$37.1M 0.12% 133
2022
Q2
$101M Buy
288,382
+38,814
+16% +$15.8M 0.18% 121
2022
Q1
$137M Sell
249,568
-7,478
-3% -$3.93M 0.21% 107
2021
Q4
$169M Sell
257,046
-54,613
-18% -$34.3M 0.24% 103
2021
Q3
$194M Sell
311,659
-102,861
-25% -$69.1M 0.3% 98
2021
Q2
$262M Buy
414,520
+5,038
+1% +$2.78M 0.41% 76
2021
Q1
$200M Sell
409,482
-119,707
-23% -$60M 0.33% 84
2020
Q4
$265M Sell
529,189
-125,172
-19% -$56M 0.47% 65
2020
Q3
$257M Sell
654,361
-72,917
-10% -$27M 0.51% 56
2020
Q2
$240M Buy
727,278
+51,751
+8% +$15M 0.51% 54
2020
Q1
$164M Sell
675,527
-34,674
-5% -$9.05M 0.43% 63
2019
Q4
$185M Buy
710,201
+78,206
+12% +$20.6M 0.38% 75
2019
Q3
$172M Buy
631,995
+32,735
+5% +$9.11M 0.38% 77
2019
Q2
$165M Buy
599,260
+111,334
+23% +$27.4M 0.37% 86
2019
Q1
$109M Buy
+487,926
New +$101M 0.25% 116
2018
Q4
Sell
-1,022
Closed -$255K 1007
2018
Q3
$255K Sell
1,022
-31
-3% -$7.53K ﹤0.01% 1024
2018
Q2
$229K Sell
1,053
-147
-12% -$30.3K ﹤0.01% 1035
2018
Q1
$230K Buy
+1,200
New +$221K ﹤0.01% 1057
2017
Q4
Sell
-1,500
Closed -$233K 1123
2017
Q3
$233K Sell
1,500
-100
-6% -$15.8K ﹤0.01% 1079
2017
Q2
$258K Sell
1,600
-212
-12% -$34.4K ﹤0.01% 1054
2017
Q1
$280K Buy
+1,812
New +$250K ﹤0.01% 1184

Other funds holding IDXX

Putnam Investments's IDXX Position: Q4 2023 in Review

Putnam Investments increased its Idexx Laboratories (IDXX) stake by 3.1% in Q4 2023, buying an estimated $2.64M and bringing the position to 189,978 shares worth $105M. The position accounts for 0.14% of the portfolio, ranked #118.

Putnam Investments first reported a position in IDXX in Q1 2017 and has held it in 26 quarters since. The position peaked at $265M in Q4 2020. 1,153 funds tracked by Wall St. Rank hold IDXX as of Q4 2023.

  • Putnam Investments held 189,978 shares of Idexx Laboratories worth $105M as of Q4 2023.
  • Putnam Investments bought 5,624 Idexx Laboratories shares in Q4 2023, an estimated $2.64M.
  • Idexx Laboratories made up 0.14% of Putnam Investments's portfolio in Q4 2023, its #118 holding.
  • Putnam Investments first reported a position in Idexx Laboratories in Q1 2017 and has held it in 26 quarters since.
  • Putnam Investments's Idexx Laboratories position peaked at $265M in Q4 2020.
  • 1,153 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2023.

Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.